Neurite Collapse and Altered ER Ca²⁺ Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S Mutation.

ABSTRACT: The Parkinson disease (PD) genetic LRRK2 gain-of-function mutations may relate to the ER pathological changes seen in PD patients at postmortem. Human induced pluripotent stem cell (iPSC)-derived neurons with the PD pathogenic LRRK2 G2019S mutation exhibited neurite collapse when challenged with the ER Ca²⁺ influx sarco/ER Ca²⁺-ATPase inhibitor thapsigargin (THP). Baseline ER Ca²⁺ levels measured with the ER Ca²⁺ indicator CEPIA-ER were lower in LRRK2 G2019S human neurons, including in differentiated midbrain dopamine neurons in vitro. After THP challenge, PD patient-derived neurons displayed increased Ca²⁺ influx and decreased intracellular Ca²⁺ buffering upon membrane depolarization. These effects were reversed following LRRK2 mutation correction by antisense oligonucleotides and gene editing. Gene expression analysis in LRRK2 G2019S neurons identified modified levels of key store-operated Ca²⁺ entry regulators, with no alterations in ER Ca²⁺ efflux. These results demonstrate PD gene mutation LRRK2 G2019S ER calcium-dependent pathogenic effects in human neurons.

SUBMITTER: Korecka JA 

PROVIDER: S-EPMC6335600 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature